Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Predictive Factors for LBP Interventional Treatment Outcomes

Completed

Conditions: Low Back Pain
Lumbar Radiculopathy

Interventions: Procedure: Sacroiliac joint injection
Procedure: Facet intervention
Procedure: Epidural steroid injection

First Posted Date: 2015-01-01

Last Posted Date: 2021-12-09

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 346

Registration Number: NCT02329951

Locations: 🇺🇸
Johns Hopkins School of Medicine, Baltimore, Maryland, United States

Ramelteon in the Prevention of Post-operative Delirium

Phase 2

Completed

Conditions: Cognitive Disorders
Delayed Emergence From Anesthesia
Delirium
Delirium, Dementia, Amnestic, Cognitive Disorders

Interventions: Drug: Ramelteon
Drug: Microcrystalline Cellulose
Drug: Riboflavin 100 mg

First Posted Date: 2014-12-24

Last Posted Date: 2020-06-30

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 80

Registration Number: NCT02324153

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.

Phase 1

Terminated

Conditions: Trigeminal Deafferentation Pain
Central Pain Syndromes
Upper Extremity Pain Due to Deafferentation of the Cervical Spine
Trigeminal Neuralgia (Burchiel Type I)
Trigeminal Neuropathic Pain
Complex Regional Pain Syndrome (Types I and II, Involving the Upper Extremity)
Glossopharyngeal Neuralgia
Trigeminal Neuralgia (Burchiel Type II)

Interventions: Device: Epidural Motor Cortex Stimulation

First Posted Date: 2014-12-22

Last Posted Date: 2019-02-18

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 1

Registration Number: NCT02321566

Locations: 🇺🇸
The Johns Hopkins Hospital, Baltimore, Maryland, United States

SteadyRx: Smartphone ART Adherence Intervention for Drug Users

Not Applicable

Completed

Conditions: Medication Adherence
HIV

Interventions: Behavioral: SteadyRx

First Posted Date: 2014-12-16

Last Posted Date: 2018-11-20

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 51

Registration Number: NCT02317614

Locations: 🇺🇸
Comprehensive Care Practice, Baltimore, Maryland, United States

Educating Nurses About Venous Thromboembolism (VTE) Prevention

Not Applicable

Completed

Conditions: Venous Thrombosis
Venous Thromboembolism

Interventions: Behavioral: Nurse education in traditional format
Behavioral: Nurse education in contemporary format

First Posted Date: 2014-11-26

Last Posted Date: 2019-05-17

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 933

Registration Number: NCT02301793

Locations: 🇺🇸
Johns Hopkins Medical Institutions, Baltimore, Maryland, United States

Miradry Treatment for Focal Axillary Hyperhidrosis

Not Applicable

Terminated

Conditions: Axillary Hyperhidrosis

Interventions: Device: MiraDry ®

First Posted Date: 2014-11-20

Last Posted Date: 2025-05-30

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 24

Registration Number: NCT02295891

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Study to Enhance Motor Acute Recovery With Intensive Training After Stroke

Not Applicable

Completed

Conditions: Stroke

Interventions: Behavioral: Device-assisted therapy
Behavioral: Therapy-based occupational therapy

First Posted Date: 2014-11-17

Last Posted Date: 2018-08-10

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 32

Registration Number: NCT02292251

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
Columbia University, New York, New York, United States
🇨🇭
University of Zurich, Zurich, Switzerland

Functional Assessment of Coronary Artery Disease by CTA Flow Encoding

Terminated

Conditions: Coronary Artery Disease

First Posted Date: 2014-11-07

Last Posted Date: 2017-12-06

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 19

Registration Number: NCT02286401

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors

Not Applicable

Terminated

Conditions: Esophageal Subepithelial Lesions

Interventions: Device: 22-gauge Procore needle (ProCore, Cook Medical Inc., Winston-Salem, NC)
Device: conventional needle-knife sphincterotome (Microknife XL; Boston Scientific Inc, Natick, Mass)

First Posted Date: 2014-11-04

Last Posted Date: 2018-10-09

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 56

Registration Number: NCT02282111

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses

Phase 1

Completed

Conditions: Neuromyelitis Optica
Neuromyelitis Optica Spectrum Disorder

Interventions: Drug: Ublituximab

First Posted Date: 2014-10-28

Last Posted Date: 2019-06-06

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 6

Registration Number: NCT02276963

Locations: 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy